Periprostatic adipose tissue interacts with prostate cancer to promote aggressive disease

Prostate cancer is now the most commonly diagnosed cancer among men in the developed world and is responsible for a significant number of cancer deaths each year (1). It has become increasingly clear that the epithelial component of the tumour itself is not the only aspect of the disease that determines clinical outcomes.